Choreo LLC’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.15M Buy
48,100
+13,030
+37% +$319K 0.01% 563
2025
Q4
$798K Sell
35,070
-2,763
-7% -$60.1K 0.01% 699
2025
Q3
$762K Buy
37,833
+5,730
+18% +$96K 0.01% 724
2025
Q2
$458K Buy
32,103
+3,778
+13% +$44.2K 0.01% 934
2025
Q1
$297K Sell
28,325
-12,368
-30% -$140K ﹤0.01% 1092
2024
Q4
$481K Sell
40,693
-8,622
-17% -$113K 0.01% 928
2024
Q3
$715K Buy
49,315
+5,373
+12% +$74.9K 0.01% 727
2024
Q2
$620K Buy
+43,942
New +$702K 0.01% 714

Other funds holding ELAN

Choreo LLC's ELAN Position: Q1 2026 in Review

Choreo LLC increased its Elanco Animal Health (ELAN) stake by 37% in Q1 2026, buying an estimated $319K and bringing the position to 48,100 shares worth $1.15M. The position accounts for 0.01% of the portfolio, ranked #563.

Choreo LLC first reported a position in ELAN in Q2 2024 and has held it in 8 quarters since. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

  • Choreo LLC held 48,100 shares of Elanco Animal Health worth $1.15M as of Q1 2026.
  • Choreo LLC bought 13,030 Elanco Animal Health shares in Q1 2026, an estimated $319K.
  • Elanco Animal Health made up 0.01% of Choreo LLC's portfolio in Q1 2026, its #563 holding.
  • Choreo LLC first reported a position in Elanco Animal Health in Q2 2024 and has held it in 8 quarters since.
  • 515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.